{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:13:20Z","timestamp":1792844000609,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.xphs.2022.02.012","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T09:21:49Z","timestamp":1645953709000},"page":"2258-2269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Intranasal Niosomal In Situ Gel As A Novel Strategy for Improving Citicoline Efficacy and Brain Delivery in Treatment of Epilepsy: In Vitro and Ex Vivo Characterization and In Vivo Pharmacodynamics Investigation"],"prefix":"10.1016","volume":"111","author":[{"given":"Marina A.","family":"Bekhet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1328-5987","authenticated-orcid":false,"given":"Adel A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Kharshoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma I. Abo","family":"El-Ela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba F.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9971","key":"10.1016\/j.xphs.2022.02.012_bib0001","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","article-title":"Epilepsy: new advances","volume":"385","author":"Mosh\u00e9","year":"2015","journal-title":"The Lancet"},{"issue":"10","key":"10.1016\/j.xphs.2022.02.012_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103113","article-title":"Application of citicoline in neurological disorders: a systematic review","volume":"12","author":"Jasielski","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0003","doi-asserted-by":"crossref","first-page":"152","DOI":"10.22336\/rjo.2017.29","article-title":"Citicoline - a neuroprotector with proven effects on glaucomatous disease","volume":"61","author":"Iulia","year":"2017","journal-title":"Rom J Ophthalmol"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0004","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: facts, doubts and unresolved issues","volume":"28","author":"Grieb","year":"2014","journal-title":"CNS Drugs"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2022.02.012_bib0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2005.07.067","article-title":"CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke","volume":"1058","author":"Adibhatla","year":"2005","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.xphs.2022.02.012_bib0006","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2022.02.012_bib0007","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/10717544.2016.1259371","article-title":"In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration","volume":"24","author":"Ammar","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2022.02.012_bib0008","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cis.2012.08.002","article-title":"Niosomes: novel sustained release nonionic stable vesicular systems\u2013an overview","volume":"183-184","author":"Mahale","year":"2012","journal-title":"Adv Colloid Interface Sci"},{"issue":"2","key":"10.1016\/j.xphs.2022.02.012_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11020055","article-title":"Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery","volume":"11","author":"Ge","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2022.02.012_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","article-title":"Stimuli-responsive in situ gelling system for nose-to-brain drug delivery","volume":"327","author":"Agrawal","year":"2020","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0011","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12249-008-9105-1","article-title":"Niosome-encapsulated gentamicin for ophthalmic controlled delivery","volume":"9","author":"Abdelbary","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.xphs.2022.02.012_bib0012","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/pharmaceutics13081197","article-title":"Berberine encapsulated lecithin\u2013chitosan nanoparticles as innovative wound healing agent in type II diabetes","volume":"13","author":"Panda","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.xphs.2022.02.012_bib0013","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.xphs.2021.04.020","article-title":"Novel chitosan-coated niosomal formulation for improved management of bacterial conjunctivitis: a highly permeable and efficient ocular nanocarrier for azithromycin","volume":"110","author":"Eid","year":"2021","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2022.02.012_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1371-6","article-title":"Development, optimization, and in vitro\/in vivo characterization of enhanced lipid nanoparticles for ocular delivery of ofloxacin: the influence of pegylation and chitosan coating","volume":"20","author":"Eid","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2022.02.012_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2017.03.039","article-title":"Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats","volume":"254","author":"Mahmoud","year":"2017","journal-title":"J control release"},{"issue":"2","key":"10.1016\/j.xphs.2022.02.012_bib0016","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08982104.2019.1610435","article-title":"Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization and in vivo evaluation","volume":"30","author":"Khallaf","year":"2020","journal-title":"J Liposome Res"},{"key":"10.1016\/j.xphs.2022.02.012_bib0017","article-title":"Transfersomal nanovesicles for nose-to-brain delivery of ofloxacin for better management of bacterial meningitis: formulation, optimization by Box-Behnken design, characterization and in vivo pharmacokinetic study","volume":"54","author":"Eid","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0018","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/10837450.2016.1219916","article-title":"Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride","volume":"22","author":"Abdelbary","year":"2017","journal-title":"Pharm Dev Technol"},{"issue":"4","key":"10.1016\/j.xphs.2022.02.012_bib0019","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/03639045.2016.1268153","article-title":"Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic\u2013pharmacodynamic modeling approach for quantitative prediction of skin absorption","volume":"43","author":"Elkomy","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2022.02.012_bib0020","first-page":"7413","article-title":"Mechanistic study of decreased skin penetration using a combination of sonophoresis with sodium fluorescein-loaded PEGylated liposomes with d-limonene","volume":"10","author":"Rangsimawong","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2022.02.012_bib0021","first-page":"4581","article-title":"Effect of liposomal fluidity on skin permeation of sodium fluorescein entrapped in liposomes","volume":"10","author":"Subongkot","year":"2015","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"10.1016\/j.xphs.2022.02.012_bib0022","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/10837450.2014.926919","article-title":"Transdermal delivery of meloxicam using niosomal hydrogels: in vitro and pharmacodynamic evaluation","volume":"20","author":"El-Badry","year":"2015","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.xphs.2022.02.012_bib0023","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jddst.2017.03.005","article-title":"Formulation development and evaluation of Natamycin niosomal in-situ gel for ophthalmic drug delivery","volume":"39","author":"Paradkar","year":"2017","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0024","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1208\/s12249-013-9986-5","article-title":"Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity","volume":"14","author":"Kumbhar","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2022.02.012_bib0025","doi-asserted-by":"crossref","DOI":"10.2147\/NDT.S50371","article-title":"Animal models of epilepsy: use and limitations","author":"Kandratavicius","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"136","key":"10.1016\/j.xphs.2022.02.012_bib0026","doi-asserted-by":"crossref","DOI":"10.3791\/56573","article-title":"Pentylenetetrazole-induced kindling mouse model","author":"Shimada","year":"2018","journal-title":"J Vis Exp"},{"issue":"1","key":"10.1016\/j.xphs.2022.02.012_bib0027","doi-asserted-by":"crossref","first-page":"81","DOI":"10.9758\/cpn.2020.18.1.81","article-title":"Protective effects of citicoline and benfotiamine each alone and in combination on streptozotocin-induced memory impairment in mice","volume":"18","author":"Safavi","year":"2020","journal-title":"Clin Psychopharm Neurosci"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0028","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.xphs.2022.02.012_bib0029","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2022.02.012_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-5173(99)00451-2","article-title":"Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts","volume":"197","author":"Tengamnuay","year":"2000","journal-title":"Int J Pharm"},{"issue":"4\u20135","key":"10.1016\/j.xphs.2022.02.012_bib0031","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejps.2007.08.006","article-title":"Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties","volume":"32","author":"Zaki","year":"2007","journal-title":"Eur J Pharm Sci"},{"issue":"105","key":"10.1016\/j.xphs.2022.02.012_bib0032","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/physci241020a0","article-title":"Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions","volume":"241","author":"Frens","year":"1973","journal-title":"Nat Phys Sci"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0033","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/mp3005885","article-title":"Multifunctional gold nanoparticles for diagnosis and therapy of disease","volume":"10","author":"Mieszawska","year":"2013","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0034","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s13346-018-0499-3","article-title":"Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer","volume":"8","author":"Salem","year":"2018","journal-title":"Drug Deliv Transl Res"},{"issue":"10","key":"10.1016\/j.xphs.2022.02.012_bib0035","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1080\/1061186X.2019.1608553","article-title":"Brain targeting of resveratrol through intranasal lipid vesicles labelled with gold nanoparticles: in vivo evaluation and bioaccumulation investigation using computed tomography and histopathological examination","volume":"27","author":"Salem","year":"2019","journal-title":"J Drug Target"},{"issue":"11","key":"10.1016\/j.xphs.2022.02.012_bib0036","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1021\/acsnano.7b04495","article-title":"In vivo neuroimaging of exosomes using gold nanoparticles","volume":"11","author":"Betzer","year":"2017","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.xphs.2022.02.012_bib0037","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1039\/C3NR04878K","article-title":"Transport of nanoparticles through the blood\u2013brain barrier for imaging and therapeutic applications","volume":"6","author":"Shilo","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.xphs.2022.02.012_bib0038","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/IJN.S276330","article-title":"Response surface optimization of ultra-elastic nanovesicles loaded with deflazacort tailored for transdermal delivery: Accentuated bioavailability and anti-inflammatory efficacy","volume":"16","author":"Ali","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2022.02.012_bib0039","series-title":"Applied Optimal Designs","author":"Berger","year":"2005"},{"issue":"19","key":"10.1016\/j.xphs.2022.02.012_bib0040","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1016\/j.ces.2007.11.034","article-title":"Model-based design of experiments for parameter precision: state of the art","volume":"63","author":"Franceschini","year":"2008","journal-title":"Chem Eng Sci"},{"key":"10.1016\/j.xphs.2022.02.012_bib0041","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7372306","article-title":"Niosomes as nanoparticular drug carriers: fundamentals and recent applications","volume":"2016","author":"Ag Seleci","year":"2016","journal-title":"J Nanomater"},{"key":"10.1016\/j.xphs.2022.02.012_bib0042","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.2147\/DDDT.S177746","article-title":"Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation","volume":"12","author":"Abou-Taleb","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2022.02.012_bib0043","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","article-title":"Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes","volume":"361","author":"Mokhtar","year":"2008","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2022.02.012_bib0044","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/10731199.2011.611476","article-title":"Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery","volume":"39","author":"Gupta","year":"2011","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"issue":"4","key":"10.1016\/j.xphs.2022.02.012_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-013-1556-y","article-title":"Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation","volume":"15","author":"Akbari","year":"2013","journal-title":"J Nanopart Res"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2022.02.012_bib0046","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2005.05.009","article-title":"Effect of cholesterol and temperature on the elastic properties of niosomal membranes","volume":"300","author":"Nasseri","year":"2005","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.xphs.2022.02.012_bib0047","article-title":"In vitro and in vivo evaluation of niosomal formulation for controlled delivery of clarithromycin","volume":"2016","author":"Shilakari Asthana","year":"2016","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.xphs.2022.02.012_bib0048","article-title":"Formulation and evaluation of topical drug delivery system containing clobetasol propionate niosomes","volume":"1","author":"Abraham Lingan","year":"2011","journal-title":"Sci. Revs Chem. Commun"},{"issue":"5","key":"10.1016\/j.xphs.2022.02.012_bib0049","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40005-014-0121-8","article-title":"Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug","volume":"44","author":"Abdelkader","year":"2014","journal-title":"J Pharmaceut Investig"},{"issue":"1","key":"10.1016\/j.xphs.2022.02.012_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(94)90228-3","article-title":"Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85)","volume":"105","author":"Yoshioka","year":"1994","journal-title":"Int J Pharmaceut"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0051","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1208\/s12249-010-9480-2","article-title":"Formulation and optimization of zidovudine niosomes","volume":"11","author":"Ruckmani","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2022.02.012_bib0052","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jps.21944","article-title":"Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery","volume":"99","author":"Bayindir","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.02.012_bib0053","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4155\/tde-2017-0005","article-title":"Intranasal melatonin nanoniosomes: pharmacokinetic, pharmacodynamics and toxicity studies","volume":"8","author":"Priprem","year":"2017","journal-title":"Ther Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2022.02.012_bib0054","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(98)00169-0","article-title":"Non-ionic surfactant based vesicles (niosomes) in drug delivery","volume":"172","author":"Uchegbu","year":"1998","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2022.02.012_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03639045.2020.1871005","article-title":"Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis","volume":"47","author":"Elkomy","year":"2021","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2022.02.012_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10856-016-5713-6","article-title":"Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide","volume":"27","author":"Shelke","year":"2016","journal-title":"J Mater Sci Mater Med"},{"issue":"5","key":"10.1016\/j.xphs.2022.02.012_bib0057","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/acer.13990","article-title":"Possible benefit and validity of supplements for alcohol use disorder","volume":"43","author":"Kang","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"10.1016\/j.xphs.2022.02.012_bib0058","doi-asserted-by":"crossref","DOI":"10.3390\/nu11071569","article-title":"Citicoline: a superior form of choline?","volume":"11","author":"Synoradzki","year":"2019","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.xphs.2022.02.012_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/nu9080815","article-title":"Neuroprotective actions of dietary choline","volume":"9","author":"Blusztajn","year":"2017","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.xphs.2022.02.012_bib0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0748233716641869","article-title":"Protective effect of citicoline against aluminum-induced cognitive impairments in rats","volume":"33","author":"Abdel-Zaher","year":"2017","journal-title":"Toxicol Ind Health"},{"issue":"11","key":"10.1016\/j.xphs.2022.02.012_bib0061","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1080\/00207454.2018.1481064","article-title":"Neuropathological profile of the pentylenetetrazol (PTZ) kindling model","volume":"128","author":"Samokhina","year":"2018","journal-title":"Int J Neurosci"},{"issue":"22","key":"10.1016\/j.xphs.2022.02.012_bib0062","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1039\/D1BM01251G","article-title":"Intranasal delivery of phenytoin-loaded nanoparticles to the brain suppresses pentylenetetrazol-induced generalized tonic clonic seizures in an epilepsy mouse model","volume":"9","author":"Yousfan","year":"2021","journal-title":"Biomater Sci"},{"issue":"6","key":"10.1016\/j.xphs.2022.02.012_bib0063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10856-016-5713-6","article-title":"Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide","volume":"27","author":"Shelke","year":"2016","journal-title":"J Mater Sci Mater Med"},{"issue":"3","key":"10.1016\/j.xphs.2022.02.012_bib0064","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10517-015-2750-y","article-title":"Increase of the seizure threshold in C57BL\/6 mice after citicoline administration","volume":"158","author":"Karpova","year":"2015","journal-title":"Bull Exp Biol Med"},{"issue":"2","key":"10.1016\/j.xphs.2022.02.012_bib0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.nbd.2004.10.006","article-title":"Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport","volume":"18","author":"Hurtado","year":"2005","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.xphs.2022.02.012_bib0066","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2007.08.004","article-title":"Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke","volume":"29","author":"Hurtado","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.xphs.2022.02.012_bib0067","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0009-9120(00)00084-9","article-title":"Effect of CDP-choline on brain acetylcholinesterase and Na(+), K(+)-ATPase in adult rats","volume":"33","author":"Plataras","year":"2000","journal-title":"Clin Biochem"},{"key":"10.1016\/j.xphs.2022.02.012_bib0068","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejphar.2016.07.048","article-title":"Evaluation of neuroprotective, anticonvulsant, sedative and anxiolytic activity of citicoline in rats","volume":"789","author":"Abdolmaleki","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.xphs.2022.02.012_bib0069","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fnins.2019.00788","article-title":"Brain insulin resistance and hippocampal plasticity: mechanisms and biomarkers of cognitive decline","volume":"13","author":"Spinelli","year":"2019","journal-title":"Front Neurosci"},{"issue":"2","key":"10.1016\/j.xphs.2022.02.012_bib0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/ijms18020345","article-title":"Micro-computed tomography detection of gold nanoparticle-labelled mesenchymal stem cells in the rat subretinal layer","volume":"18","author":"Mok","year":"2017","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492200082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492200082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:38:02Z","timestamp":1758361082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492200082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S002235492200082X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.02.012","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal Niosomal In Situ Gel As A Novel Strategy for Improving Citicoline Efficacy and Brain Delivery in Treatment of Epilepsy: In Vitro and Ex Vivo Characterization and In Vivo Pharmacodynamics Investigation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}